4月1日 - ** 医疗设备制造商 Beyond Air XAIR.O 的股价盘前上涨约 11% 至 77 美分
** 该公司称已与美国一家大型集团采购组织达成协议，近 2,000 家医院可使用其 LungFit PH 设备
** LungFit PH 可提供吸入式一氧化氮，这种疗法通过放松肺部血管和提高氧含量来帮助患有严重呼吸衰竭的新生儿 - XAIR
** 公司称，全国团购协议使医院更容易评估和采用 LungFit PH，它能从室内空气中产生一氧化氮，无需气罐
** 称该协议建立在与包括 Vizient 和 Premier 在内的领先团购组织现有合作关系的基础上，并扩大了其在美国市场的覆盖范围
** 最后收盘时，股价年累计下跌约 52%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.